1. Home
  2. RNST vs EVO Comparison

RNST vs EVO Comparison

Compare RNST & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$36.58

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.67

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
EVO
Founded
1904
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RNST
EVO
Price
$36.58
$3.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$43.33
$7.00
AVG Volume (30 Days)
546.4K
250.0K
Earning Date
01-27-2026
11-05-2025
Dividend Yield
2.52%
N/A
EPS Growth
N/A
N/A
EPS
1.84
N/A
Revenue
$775,309,000.00
$887,396,457.00
Revenue This Year
$43.37
N/A
Revenue Next Year
$13.13
$8.52
P/E Ratio
$19.88
N/A
Revenue Growth
13.04
N/A
52 Week Low
$26.97
$2.84
52 Week High
$40.40
$4.80

Technical Indicators

Market Signals
Indicator
RNST
EVO
Relative Strength Index (RSI) 56.11 71.81
Support Level $35.32 $3.10
Resistance Level $36.47 $3.23
Average True Range (ATR) 0.71 0.08
MACD -0.07 0.08
Stochastic Oscillator 65.49 99.38

Price Performance

Historical Comparison
RNST
EVO

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: